Fredrikson & Byron Represents Medtronic in its Transaction with QT Vascular

May 17, 2017

Fredrikson & Byron acted as legal counsel to Medtronic, Inc., the global leader in medical technology headquartered in Minneapolis (NYSE: MDT), in its transaction with QT Vascular Ltd. for the option to acquire QT Vascular’s non-drug coated Chocolate® PTA. QT Vascular is a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease.

Fredrikson’s legal team was led by Robert Oberlies, Jeffrey Steinle, Ann Ladd, Asmah Tareen and Carrie Rosenberry.

Read the news release.